Published in Eur J Pharm Sci on July 01, 2001
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44
CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab (2008) 2.06
Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev (2010) 1.52
Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol (2012) 1.46
Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab Dispos (2010) 1.27
A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab Dispos (2010) 1.26
Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol (2009) 1.17
In vitro models for liver toxicity testing. Toxicol Res (Camb) (2012) 1.13
In vitro platforms for evaluating liver toxicity. Exp Biol Med (Maywood) (2014) 1.11
Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol (2010) 1.11
Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation. Curr Pharmacogenomics Person Med (2009) 1.10
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? Br J Clin Pharmacol (2013) 0.98
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep (2016) 0.96
Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures. Toxicol Appl Pharmacol (2008) 0.96
Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor. Drug Metab Dispos (2009) 0.95
Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues. Tissue Eng Part A (2014) 0.95
Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res (2010) 0.94
Interactions between the cytochrome P450 system and the second-generation antipsychotics. J Psychiatry Neurosci (2003) 0.93
Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol (2003) 0.89
Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects. Br J Clin Pharmacol (2009) 0.89
Label-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopy. PLoS One (2012) 0.88
Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models. J Pharmacol Exp Ther (2011) 0.88
Assessment of compound hepatotoxicity using human plateable cryopreserved hepatocytes in a 1536-well-plate format. Assay Drug Dev Technol (2011) 0.86
The role of constitutive androstane receptor in oxazaphosphorine-mediated induction of drug-metabolizing enzymes in human hepatocytes. Pharm Res (2011) 0.86
Zebrafish as model organisms for studying drug-induced liver injury. Br J Clin Pharmacol (2014) 0.85
Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity. Toxicol Appl Pharmacol (2010) 0.85
Quantitative high-throughput identification of drugs as modulators of human constitutive androstane receptor. Sci Rep (2015) 0.84
Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. Sci Rep (2016) 0.81
Rhein Elicits In Vitro Cytotoxicity in Primary Human Liver HL-7702 Cells by Inducing Apoptosis through Mitochondria-Mediated Pathway. Evid Based Complement Alternat Med (2015) 0.80
Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation. Int J Stem Cells (2015) 0.80
Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells. J Pharmacol Exp Ther (2010) 0.80
Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chem Biol Interact (2015) 0.80
Pregnane X receptor and drug-induced liver injury. Expert Opin Drug Metab Toxicol (2014) 0.79
Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates. Curr Drug Metab (2009) 0.79
Microphysical space of a liver sinusoid device enables simplified long-term maintenance of chimeric mouse-expanded human hepatocytes. Biomed Microdevices (2014) 0.79
Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B (2016) 0.78
Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies. Pharmacol Res Perspect (2015) 0.78
Commentary on prevention a possible drug-drug interaction: is concurrent administration of orlistat and pioglitazone increase the risk of durg-induced hepatotoxicity? Int J Prev Med (2015) 0.77
Cross-species gene expression analysis of species specific differences in the preclinical assessment of pharmaceutical compounds. PLoS One (2014) 0.77
A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison. Br J Clin Pharmacol (2012) 0.77
Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment. J Clin Med (2014) 0.76
Organ-on-a-Chip: New Platform for Biological Analysis. Anal Chem Insights (2015) 0.76
Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering. J Mater Chem B Mater Biol Med (2016) 0.75
Development of a pneumatically driven active cover lid for multi-well microplates for use in perfusion three-dimensional cell culture. Sci Rep (2015) 0.75
Models and methods for in vitro testing of hepatic gap junctional communication. Toxicol In Vitro (2015) 0.75
Liver Cell Culture Devices. Cell Med (2010) 0.75
Intracellular drug bioavailability: a new predictor of system dependent drug disposition. Sci Rep (2017) 0.75
Evaluation of a novel PXR-knockout in HepaRG(™) cells. Pharmacol Res Perspect (2016) 0.75
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Arch Toxicol (2017) 0.75
Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance. Hum Cell (2017) 0.75
Cytochrome P4502A6 stability in a mini organ culture model of human nasal mucosa for genotoxicology studies as detected by flow cytometry. Eur Arch Otorhinolaryngol (2008) 0.75